Project Grant R01AI160387
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $153,568 to the University of California, Los Angeles (UCLA) to conduct research on the role of interferon epsilon (IFNε) in the immune response against the protozoan parasite Trichomonas vaginalis. The research aims to: 1) determine which steps in the IFNε-mediated type I interferon response are blocked by...
- This $462,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports research to establish the epigenetic mechanisms that govern embryonic stem cell (ESC) biology. The research aims to define how ESC gene expression programs and biology are regulated by DNA methylation and the TET family of DNA demethylases. Key objectives include: Dissecting the molecular and biological requirements...
- This three-year Project Grant from the National Science Foundation's Division of Molecular and Cellular Biosciences totals $1,512,792 to fund research at Louisiana State University examining the gene regulatory networks affected by purine catabolites in bacterial pathogens. The research aims to identify additional transcription factors in Burkholderia thailandensis responsive to urate and xanthine, which accumulate in host tissues during infection due to production of reactive oxygen species....
- This three-year, $828,217 National Science Foundation project grant supports collaborative research on RNA processing in trypanosome mitochondria at Texas A&M Agrilife Research. Funded under the Biological Sciences program (CFDA 47.074), the award will advance understanding of gene expression regulation in the single-celled parasites that cause sleeping sickness. Specifically, the award funds three objectives investigating how mRNA editing is differentially controlled across the life cycle...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), is providing $450,766 to support research on the molecular mechanisms by which the bacterium Chlamydia trachomatis, the leading cause of sexually transmitted bacterial infections, modulates the function of host cell organelles and their communication to create a favorable intracellular environment for replication....
- This Project Grant award from the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) provides $1,199,999.00 to the University of Southern California (USC) to study the molecular mechanisms of DNA N6-adenine methylation (6mA) in the unicellular eukaryotic model organism Tetrahymena thermophila. The research aims to map 6mA across the Tetrahymena genome using advanced DNA sequencing techniques, providing insights into how this DNA modification is involved in gene...
- This $800,000 Project Grant, awarded by the National Science Foundation (NSF) Biological Sciences (CFDA 47.074) program, supports research to study the generation, maintenance, and function of extrachromosomal DNA (eDNA) in the malaria parasite Plasmodium. Key objectives include evaluating the connections between chromosomal genes and eDNA, the propensity for eDNA diversity, the cellular pathways and sequences contributing to eDNA generation and stability, and the clustering of eDNA within the...
- This three-year, five-hundred twenty-three thousand four-hundred sixty-one dollar project grant from the National Science Foundation's Division of Molecular and Cellular Biosciences will fund research into RNA processing in trypanosome mitochondria. The grant was awarded to Seattle Children's Research Institute on April 1, 2022 and will be completed by March 31, 2025. The project aims to advance understanding of gene expression regulation in trypanosomes, single-celled parasites that alternate...
- This $453,429 federal Project Grant awarded by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to investigate the regulation of RNA editing in the life cycle stages of the parasitic protozoan Trypanosoma brucei. The research aims to elucidate the key proteins and mechanisms underlying differential RNA editing across the parasite's development in mammalian and insect hosts. The project, conducted by Texas A&M...
- This Project Grant award of $427,604 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to elucidate the molecular mechanisms of conoid extrusion in the pathogen Toxoplasma gondii. The goal is to reconstitute the core elements of the parasite's apical complex, including actin, myosin, and a formin, in vitro to gain a mechanistic understanding of how the conoid structure is extruded...
DNA METHYLATION, 3D GENOME ORGANIZATION AND GENE EXPRESSION DURING TRICHOMONAS VAGINALIS: HOST INTERACTION - DNA METHYLATION, 3D GENOME ORGANIZATION AND GENE EXPRESSION DURING TRICHOMONAS VAGINALIS: HOST INTERACTION ABSTRACT TRICHOMONAS VAGINALIS IS A COMMON SEXUALLY TRANSMITTED PARASITE THAT COLONIZES THE HUMAN UROGENITAL TRACT CAUSING INFECTIONS THAT RANGE FROM ASYMPTOMATIC TO HIGHLY INFLAMMATORY. CHRONIC INFECTIONS CAN LEAD TO SEVERE COMPLICATIONS SUCH AS INFERTILITY, PREMATURE BIRTH DURING PREGNANCY, INCREASES THE RISK OF ACQUIRING HIV, CERVICAL CANCER AND AGGRESSIVE PROSTATE CANCER. HENCE, UNDERSTANDING HOW THE PROCESS OF INFECTION IN TRICHOMONAS PARASITE IS REGULATED REMAINS AN IMPORTANT GOAL IN PARASITOLOGY RESEARCH AND HUMAN HEALTH. HOST: PARASITE INTERACTION IS REGULATED BY CHANGES IN GENE EXPRESSION, BUT IT IS STILL LARGELY UNKNOWN HOW THESE CHANGES IN TRANSCRIPTIONAL PROFILES ARE CONTROLLED AS VERY FEW TRANSCRIPTIONAL REGULATORY ELEMENTS HAVE BEEN DESCRIBED. OUR RECENT WORKS HIGHLIGHTED THE IMPORTANCE OF EPIGENETICS IN THE REGULATION OF TRANSCRIPTION AND POSSIBLE ROLE IN PARASITE PATHOGENESIS. SPECIFICALLY, WE ANALYZED THE ABUNDANCE OF DNA METHYLATION DEMONSTRATING THAT N6-METHYLADENINE (6MA), AND NOT 5-METHYLCYTOSINE (5MC), IS THE MAIN DNA METHYLATION MARK IN T. VAGINALIS. GENOME-WIDE DISTRIBUTION OF 6MA REVEALS THAT THIS MARK IS ENRICHED AT INTERGENIC REGIONS, WITH A PREFERENCE FOR CERTAIN SUPERFAMILIES OF DNA TRANSPOSABLE ELEMENTS. INTERESTINGLY, BIOINFORMATICS ANALYSIS REVEALED THE PRESENCE OF TRANSCRIPTIONALLY ACTIVE OR REPRESSIVE INTERVALS FLANKED BY 6MA-ENRICHED REGIONS AND RESULTS FROM CHROMATIN CONFORMATION CAPTURE (3C) EXPERIMENTS SUGGEST THESE 6MA FLANKED REGIONS ARE IN CLOSE SPATIAL PROXIMITY. THIS FINDING REVEALED A NEW ROLE FOR 6MA IN MODULATING 3D CHROMATIN STRUCTURE AND GENE EXPRESSION IN THIS PARASITE. BASED ON THESE ANTECEDENTS WE NOW PROPOSE THAT 6MA COULD BE A KEY REGULATOR OF 3D GENOME ARCHITECTURE BY MODULATING EXPRESSION OF TRANSCRIPTIONAL- MODULES OF GENES DURING PARASITE INFECTION. THREE-DIMENSIONAL ARRANGEMENT OF DNA IN THE NUCLEUS ARE INCREASINGLY SEEN AS KEY CONTRIBUTORS TO THE REGULATION OF GENE EXPRESSION BUT STUDIES ON HOW GENOME STRUCTURE AND NUCLEAR ORGANIZATION INFLUENCE TRANSCRIPTION HAVE SO FAR BEEN LIMITED TO A HANDFUL OF MODEL SPECIES. GUIDED BY STRONG PRELIMINARY DATA, WE PROPOSE TO PURSUE THREE SPECIFIC AIMS TO FURTHER ANALYZE THE ROLE OF 6MA IN THE REGULATION OF 3D GENOME CONFORMATION AND GENE EXPRESSION DURING THE PROCESS OF PARASITE ATTACHMENT TO HOST CELLS. THESE RESULTS WILL PROVIDE NEW INSIGHTS INTO T. VAGINALIS EPIGENETIC REGULATION THAT MAY HELP TO UNDERSTAND THE MECHANISMS THAT LEAD TO PARASITE ADHERENCE AND CYTOTOXICITY; KEY STEPS TOWARD DISSECTING THE SPECIFIC OUTCOMES OF TRICHOMONAS INFECTION. IMPORTANTLY, THE ASSOCIATION OF 6MA WITH CHROMATIN LOOPING IS NOTEWORTHY BECAUSE IT POINTS TO A NOVEL FUNCTION FOR THIS EPIGENETIC MARK IN EUKARYOTES WITH SCARCE 5MC LEVELS. 1
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $131.8k | 3/20/25 | ||
| Not listed | $13.1k | 4/17/24 | ||
| Not listed | $13.1k | 4/17/24 | ||
| Not listed | $117.8k | 2/21/24 | ||
| Not listed | $117.8k | 2/21/24 |